Matches in SemOpenAlex for { <https://semopenalex.org/work/W2012939939> ?p ?o ?g. }
- W2012939939 endingPage "8351" @default.
- W2012939939 startingPage "8339" @default.
- W2012939939 abstract "Bioactive peptides have evolved to optimally fulfill specific biological functions, a fact which has long attracted attention for their use as therapeutic agents. While there have been some recent commercial successes fostered in part by advances in large-scale peptide synthesis, development of peptides as therapeutic agents has been significantly impeded by their inherent susceptibility to protease degradation in the bloodstream. Here we report that incorporation of specially designed amino acid analogues at the P1′ position, directly C-terminal of the enzyme cleavage site, renders peptides, including glucagon-like peptide-1 (7–36) amide (GLP-1) and six other examples, highly resistant to serine protease degradation without significant alteration of their biological activity. We demonstrate the applicability of the method to a variety of proteases, including dipeptidyl peptidase IV (DPP IV), dipeptidyl peptidase 8 (DPP8), fibroblast activation protein α (FAPα), α-lytic protease (αLP), trypsin, and chymotrypsin. In summary, the “P1′ modification” represents a simple, general, and highly adaptable method of generating enzymatically stable peptide-based therapeutics." @default.
- W2012939939 created "2016-06-24" @default.
- W2012939939 creator A5003681632 @default.
- W2012939939 creator A5008358568 @default.
- W2012939939 creator A5010459598 @default.
- W2012939939 creator A5019236825 @default.
- W2012939939 creator A5019682038 @default.
- W2012939939 creator A5026836971 @default.
- W2012939939 creator A5035978194 @default.
- W2012939939 creator A5061574958 @default.
- W2012939939 creator A5061637003 @default.
- W2012939939 creator A5076533789 @default.
- W2012939939 creator A5079399311 @default.
- W2012939939 creator A5079683616 @default.
- W2012939939 creator A5081337790 @default.
- W2012939939 creator A5088957318 @default.
- W2012939939 date "2013-10-16" @default.
- W2012939939 modified "2023-09-23" @default.
- W2012939939 title "A General Method for Making Peptide Therapeutics Resistant to Serine Protease Degradation: Application to Dipeptidyl Peptidase IV Substrates" @default.
- W2012939939 cites W1495857714 @default.
- W2012939939 cites W1545804167 @default.
- W2012939939 cites W1950912961 @default.
- W2012939939 cites W1967295307 @default.
- W2012939939 cites W1967772715 @default.
- W2012939939 cites W1975804012 @default.
- W2012939939 cites W1980130009 @default.
- W2012939939 cites W1981795914 @default.
- W2012939939 cites W1982077841 @default.
- W2012939939 cites W1983327974 @default.
- W2012939939 cites W1986522335 @default.
- W2012939939 cites W1990996794 @default.
- W2012939939 cites W1992452630 @default.
- W2012939939 cites W1992773726 @default.
- W2012939939 cites W1993197242 @default.
- W2012939939 cites W1996286115 @default.
- W2012939939 cites W1998200369 @default.
- W2012939939 cites W2003893098 @default.
- W2012939939 cites W2004690438 @default.
- W2012939939 cites W2008497683 @default.
- W2012939939 cites W2013184139 @default.
- W2012939939 cites W2013898766 @default.
- W2012939939 cites W2015529507 @default.
- W2012939939 cites W2017086778 @default.
- W2012939939 cites W2022291462 @default.
- W2012939939 cites W2024054722 @default.
- W2012939939 cites W2031468509 @default.
- W2012939939 cites W2031795846 @default.
- W2012939939 cites W2032541516 @default.
- W2012939939 cites W2032833845 @default.
- W2012939939 cites W2035979242 @default.
- W2012939939 cites W2037660982 @default.
- W2012939939 cites W2046703119 @default.
- W2012939939 cites W2054569491 @default.
- W2012939939 cites W2059053844 @default.
- W2012939939 cites W2063608942 @default.
- W2012939939 cites W2068399304 @default.
- W2012939939 cites W2072847824 @default.
- W2012939939 cites W2079681415 @default.
- W2012939939 cites W2084140416 @default.
- W2012939939 cites W2087638953 @default.
- W2012939939 cites W2087707716 @default.
- W2012939939 cites W2088877201 @default.
- W2012939939 cites W2094141131 @default.
- W2012939939 cites W2095327052 @default.
- W2012939939 cites W2098327527 @default.
- W2012939939 cites W2101545809 @default.
- W2012939939 cites W2104763836 @default.
- W2012939939 cites W2132295069 @default.
- W2012939939 cites W2135978651 @default.
- W2012939939 cites W2149381414 @default.
- W2012939939 cites W2154497567 @default.
- W2012939939 cites W75575892 @default.
- W2012939939 doi "https://doi.org/10.1021/jm400423p" @default.
- W2012939939 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24044354" @default.
- W2012939939 hasPublicationYear "2013" @default.
- W2012939939 type Work @default.
- W2012939939 sameAs 2012939939 @default.
- W2012939939 citedByCount "15" @default.
- W2012939939 countsByYear W20129399392015 @default.
- W2012939939 countsByYear W20129399392016 @default.
- W2012939939 countsByYear W20129399392018 @default.
- W2012939939 countsByYear W20129399392019 @default.
- W2012939939 countsByYear W20129399392020 @default.
- W2012939939 countsByYear W20129399392022 @default.
- W2012939939 crossrefType "journal-article" @default.
- W2012939939 hasAuthorship W2012939939A5003681632 @default.
- W2012939939 hasAuthorship W2012939939A5008358568 @default.
- W2012939939 hasAuthorship W2012939939A5010459598 @default.
- W2012939939 hasAuthorship W2012939939A5019236825 @default.
- W2012939939 hasAuthorship W2012939939A5019682038 @default.
- W2012939939 hasAuthorship W2012939939A5026836971 @default.
- W2012939939 hasAuthorship W2012939939A5035978194 @default.
- W2012939939 hasAuthorship W2012939939A5061574958 @default.
- W2012939939 hasAuthorship W2012939939A5061637003 @default.
- W2012939939 hasAuthorship W2012939939A5076533789 @default.
- W2012939939 hasAuthorship W2012939939A5079399311 @default.
- W2012939939 hasAuthorship W2012939939A5079683616 @default.
- W2012939939 hasAuthorship W2012939939A5081337790 @default.